Revenue Growth Driven by Core Operations
Total revenue increased 4.6% YoY to $68.5B in Q1 2026 from $65.5B in Q1 2025, reflecting continued expansion across Cigna's health services and pharmacy benefit management segments.
Cigna Group is expected to release its Q2 2026 10-Q filing in the upcoming earnings season. Last quarter: Cigna Group (CI) delivered solid Q1 2026 results with revenue up 4.6% YoY to $68.5B and net income surging 25.0% to $1.65B, though operating cash flow declined sharply by 41.1% and cost of revenue grew faster than revenue at 11.8%.
Drawn from management commentary in the Q1 2026 10-Q:
Total revenue increased 4.6% YoY to $68.5B in Q1 2026 from $65.5B in Q1 2025, reflecting continued expansion across Cigna's health services and pharmacy benefit management segments.
Net income rose 25.0% YoY to $1.65B, with diluted EPS jumping 29.1% to $6.26 from $4.85, indicating meaningful operating leverage and potentially favorable mix shifts or one-time items benefiting profitability.
Cost of revenue grew 11.8% YoY to $54.1B, significantly faster than the 4.6% revenue growth, compressing gross profit and suggesting rising medical costs or pharmacy benefit costs that management must manage carefully.
Revenue
$68.49B
++4.57% YoY
EPS (Basic)
$6.30
++29.10% YoY
Operating Income
$2.36B
++19.63% YoY
Add CI to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.